M. Allewelt

732 total citations
20 papers, 515 citations indexed

About

M. Allewelt is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Speech and Hearing. According to data from OpenAlex, M. Allewelt has authored 20 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 7 papers in Epidemiology and 4 papers in Speech and Hearing. Recurrent topics in M. Allewelt's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Pneumonia and Respiratory Infections (4 papers) and Tracheal and airway disorders (4 papers). M. Allewelt is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Pneumonia and Respiratory Infections (4 papers) and Tracheal and airway disorders (4 papers). M. Allewelt collaborates with scholars based in Germany and United States. M. Allewelt's co-authors include H. Lode, Gregory P. Priebe, Gerald B. Pier, Fadie T. Coleman, Martha Grout, H. Mauch, Jeanette Schulz‐Menger, C Grohé, Fabian Muehlberg and H. Semper and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Infection and Immunity and Clinical Microbiology and Infection.

In The Last Decade

M. Allewelt

19 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Allewelt Germany 8 174 166 112 112 78 20 515
Yake Yao China 11 97 0.6× 142 0.9× 79 0.7× 116 1.0× 29 0.4× 38 436
Jean-Yves Fagon France 9 190 1.1× 224 1.3× 85 0.8× 104 0.9× 34 0.4× 15 616
Goh Ohji Japan 13 82 0.5× 192 1.2× 82 0.7× 61 0.5× 39 0.5× 47 510
A Penketh United Kingdom 15 636 3.7× 230 1.4× 107 1.0× 106 0.9× 65 0.8× 23 971
Norihito Kaku Japan 15 84 0.5× 196 1.2× 154 1.4× 210 1.9× 23 0.3× 64 660
Qijian Cheng China 12 161 0.9× 277 1.7× 99 0.9× 37 0.3× 25 0.3× 31 568
J Wedgwood Switzerland 12 241 1.4× 361 2.2× 94 0.8× 156 1.4× 22 0.3× 13 766
Laura Lega Italy 9 102 0.6× 213 1.3× 82 0.7× 26 0.2× 27 0.3× 15 538
J. J. Granizo Spain 12 113 0.6× 272 1.6× 40 0.4× 58 0.5× 24 0.3× 14 449
A Equi United Kingdom 6 421 2.4× 176 1.1× 92 0.8× 56 0.5× 10 0.1× 7 541

Countries citing papers authored by M. Allewelt

Since Specialization
Citations

This map shows the geographic impact of M. Allewelt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Allewelt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Allewelt more than expected).

Fields of papers citing papers by M. Allewelt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Allewelt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Allewelt. The network helps show where M. Allewelt may publish in the future.

Co-authorship network of co-authors of M. Allewelt

This figure shows the co-authorship network connecting the top 25 collaborators of M. Allewelt. A scholar is included among the top collaborators of M. Allewelt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Allewelt. M. Allewelt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Semper, Hannes, et al.. (2017). Drug-induced myocarditis after nivolumab treatment in a patient with PDL-1-negative squamous cell carcinoma of the lung. Pneumologie. 71(S 01). S1–S125. 3 indexed citations
2.
Semper, H., Fabian Muehlberg, Jeanette Schulz‐Menger, M. Allewelt, & C Grohé. (2016). Drug-induced myocarditis after nivolumab treatment in a patient with PDL1- negative squamous cell carcinoma of the lung. Lung Cancer. 99. 117–119. 82 indexed citations
3.
Costabel, Ulrich, Dirk Skowasch, Stefan Pabst, et al.. (2014). Diagnostik und Therapie der kardialen Sarkoidose. Pneumologie. 68(2). 124–132. 13 indexed citations
5.
Ott, Sebastian R., et al.. (2008). Moxifloxacin vs Ampicillin/Sulbactam in Aspiration Pneumonia and Primary Lung Abscess. Infection. 36(1). 23–30. 60 indexed citations
6.
Allewelt, M., et al.. (2008). Wandel im Erregerspektrum ambulant erworbener Pneumonien (1982-1992). DMW - Deutsche Medizinische Wochenschrift. 122(34/35). 1027–1032. 1 indexed citations
7.
Lode, H., M. Allewelt, H. Mauch, & Sebastian R. Ott. (2008). Ampicillin/Sulbactam for the Treatment of Aspiration Pneumonia and Primary Lung Abscess. International Journal of Infectious Diseases. 12. e210–e210. 1 indexed citations
8.
Lode, H., et al.. (2007). A Prediction Model for Bacterial Etiology in Acute Exacerbations of COPD. Infection. 35(3). 143–149. 62 indexed citations
9.
Allewelt, M.. (2007). Aspiration pneumonia and primary lung abscess: diagnosis and therapy of an aerobic or an anaerobic infection?. Expert Review of Respiratory Medicine. 1(1). 111–119. 7 indexed citations
10.
Roth, Aleeza J., et al.. (2006). Serologische Frühdiagnostik der Mykoplasmenpneumonie. DMW - Deutsche Medizinische Wochenschrift. 131(12). 613–617. 1 indexed citations
11.
Allewelt, M. & H. Lode. (2005). Diagnostik bei Hämoptysen/Hämoptoe. DMW - Deutsche Medizinische Wochenschrift. 130(9). 450–452. 5 indexed citations
12.
Allewelt, M., et al.. (2004). Die chronische eosinophile Pneumonie (CEP). DMW - Deutsche Medizinische Wochenschrift. 129(36). 1858–1860.
13.
Allewelt, M., Patrick J. Schuler, P Bölcskei, H. Mauch, & H. Lode. (2004). Ampicillin + sulbactam vs. clindamycin ± cephalosporin for the treatment of aspiration pneumonia and primary lung abscess. Clinical Microbiology and Infection. 10(2). 163–170. 76 indexed citations
14.
Pletz, Mathias W., et al.. (2003). ABT-773: Pharmacokinetics and Interactions with Ranitidine and Sucralfate. Antimicrobial Agents and Chemotherapy. 47(3). 1129–1131. 10 indexed citations
15.
Burkhardt, Olaf, M. Allewelt, Mathias W. Pletz, Tobias Welte, & H. Lode. (2003). Beau's Lines in a Patient Treated with Moxifloxacin for Anaerobic Pulmonary Infection. Scandinavian Journal of Infectious Diseases. 35(8). 517–518. 3 indexed citations
16.
Allewelt, M. & H. Lode. (2003). Saisonale Einfl�sse auf bakterielle respiratorische Infektionen im Kindes- und Erwachsenenalter. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 46(1). 2–8. 1 indexed citations
17.
Burkhardt, Olaf, Klaus Borner, Heino Staß, et al.. (2002). Single- and Multiple-dose Pharmacokinetics of Oral Moxifloxacin and Clarithromycin, and Concentrations in Serum, Saliva and Faeces. Scandinavian Journal of Infectious Diseases. 34(12). 898–903. 31 indexed citations
18.
Allewelt, M. & H. Lode. (2001). Diagnosis and treatment of aspiration pneumonia and primary lung abscess. Therapeutische Umschau. 58(10). 599–603. 5 indexed citations
19.
Allewelt, M., Fadie T. Coleman, Martha Grout, Gregory P. Priebe, & Gerald B. Pier. (2000). Acquisition of Expression of the Pseudomonas aeruginosa ExoU Cytotoxin Leads to Increased Bacterial Virulence in a Murine Model of Acute Pneumonia and Systemic Spread. Infection and Immunity. 68(7). 3998–4004. 148 indexed citations
20.
Allewelt, M. & Susan Hauser. (1997). [Neytumorin as biomodular onco-therapy--allegations without documentation].. PubMed. 86(18). 750–61. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026